You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 11, March 16, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Thyroidectomy for amiodarone-induced thyrotoxicosis

A. P. Farwell, S. L. Abend, S. K. Huang, N. A. Patwardhan and L. E. Braverman
Division of Endocrinology and Metabolism, University of Massachusetts Medical School, Worcester 01655.

Amiodarone hydrochloride, an iodine-rich drug used in the treatment of tachyarrhythmias, is responsible for the development of thyrotoxicosis in approximately 10% of patients who reside in areas of moderate iodine deficiency. Treatment of amiodarone-induced thyrotoxicosis is difficult since the drug has a prolonged half-life, cardiac decompensation due to underlying heart disease occurs often, and discontinuation of amiodarone therapy may not be possible. We report a patient with severe thyrotoxicosis who received amiodarone for 34 months. Prolonged treatment with methimazole, potassium perchlorate, iopanoic acid, and dexamethasone was unsuccessful in controlling the hyperthyroid state. A near-total thyroidectomy resulted in rapid amelioration of thyrotoxicosis. Since surgery results in rapid control of thyrotoxicosis and permits continued therapy with amiodarone, we suggest that near-total thyroidectomy warrants consideration as definitive treatment for resistant amiodarone-induced thyrotoxicosis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glucocorticoid Response in Amiodarone-Induced Thyrotoxicosis Resulting from Destructive Thyroiditis Is Predicted by Thyroid Volume and Serum Free Thyroid Hormone Concentrations
Bogazzi et al.
J. Clin. Endocrinol. Metab. 2007;92:556-562.
ABSTRACT | FULL TEXT  

Treatment of Type II Amiodarone-Induced Thyrotoxicosis by Either Iopanoic Acid or Glucocorticoids: A Prospective, Randomized Study
Bogazzi et al.
J. Clin. Endocrinol. Metab. 2003;88:1999-2002.
ABSTRACT | FULL TEXT  

Use of Oral Cholecystographic Agents in the Treatment of Amiodarone-Induced Hyperthyroidism
Chopra and Baber
J. Clin. Endocrinol. Metab. 2001;86:4707-4710.
ABSTRACT | FULL TEXT  

The Effects of Amiodarone on the Thyroid
Martino et al.
Endocr. Rev. 2001;22:240-254.
ABSTRACT | FULL TEXT  

Amiodarone-Induced Thyrotoxicosis
Daniels
J. Clin. Endocrinol. Metab. 2001;86:3-8.
FULL TEXT  

Amiodarone Induces Cytochrome c Release and Apoptosis through an Iodine-Independent Mechanism
Di Matola et al.
J. Clin. Endocrinol. Metab. 2000;85:4323-4330.
ABSTRACT | FULL TEXT  

Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy
Newman et al.
Heart 1998;79:121-127.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.